Gorringe
Andrew R. Gorringe, Wiltshire GB
Patent application number | Description | Published |
---|---|---|
20090041807 | Stable Compositions Containing Omvs - An OMV preparation comprises OMVs having a sufficiently positive or negative surface charge to substantially prevent aggregation. | 02-12-2009 |
Andrew Richard Gorringe, Salisbury GB
Patent application number | Description | Published |
---|---|---|
20090148469 | Multicomponent meningococcal vaccine - A composition is provided comprising | 06-11-2009 |
20110033491 | MULTICOMPONENT MENINGOCOCCAL VACCINE - A composition is provided comprising | 02-10-2011 |
Andrew Richard Gorringe, Wiltshire GB
Patent application number | Description | Published |
---|---|---|
20100092519 | COMPOSITIONS COMPRISING POLYSACCHARIDE CONJUGATES AND THEIR USE AS VACCINES - The present invention is in the field of combination therapies, including vaccine compositions, which comprise polysaccharide-protein conjugates and outer membrane vesicles (OMVs) from commensal bacteria, particularly commensal | 04-15-2010 |
Lee J. Gorringe, Ware GB
Patent application number | Description | Published |
---|---|---|
20090148518 | Pharmaceutical Formulations - The present invention is directed to novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection moulding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form. | 06-11-2009 |
Lee J. Gorringe, Hertfordshire GB
Patent application number | Description | Published |
---|---|---|
20110117190 | Pharmaceutical Formulations - The present invention is directed to novel pharmaceutically acceptable polymeric compositions suitable for melt extrusion and injection moulding of single or multi-component pharmaceutical dosage forms comprising a plurality of drug substance containing sub-units, being capsule compartments and/or solid sub-units comprising a solid matrix of a polymer which contains a drug substance, the sub-units being connected together in the assembled dosage form. | 05-19-2011 |